Verici Dx (VRCI) Competitors

GENinCode (LON:GENI) and Verici Dx (LON:VRCI) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their media sentiment, valuation, dividends, community ranking, institutional ownership, analyst recommendations, risk, earnings and profitability.

Does the media favor GENI or VRCI?

In the previous week, GENinCode and GENinCode both had 1 articles in the media. Verici Dx's average media sentiment score of 0.00 beat GENinCode's score of -1.27 indicating that GENinCode is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
GENinCode	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Verici Dx	0 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Negative

Which has more volatility & risk, GENI or VRCI?

GENinCode has a beta of 0.66, meaning that its stock price is 34% less volatile than the S&P 500. Comparatively, Verici Dx has a beta of 1.53, meaning that its stock price is 53% more volatile than the S&P 500.

Do analysts prefer GENI or VRCI?

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
GENinCode	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	N/A
Verici Dx	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	N/A

Does the MarketBeat Community believe in GENI or VRCI?

GENinCode and Verici Dx both received 0 outperform votes by MarketBeat users.

Company	Underperform	Outperform
GENinCode	N/A	N/A
Verici Dx	N/A	N/A

Which has preferable earnings & valuation, GENI or VRCI?

GENinCode has higher revenue and earnings than Verici Dx. Verici Dx is trading at a lower price-to-earnings ratio than GENinCode, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
GENinCode	£1.72M	9.00	-£6.73M	-£0.06	-145.83
Verici Dx	N/A	N/A	-£11.21M	-£0.05	-165.00

Is GENI or VRCI more profitable?

Verici Dx's return on equity of -84.23% beat GENinCode's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
GENinCode	N/A	-84.23%	-43.64%
Verici Dx	N/A	-92.28%	-47.86%

Do institutionals and insiders believe in GENI or VRCI?

41.6% of GENinCode shares are owned by institutional investors. Comparatively, 47.4% of Verici Dx shares are owned by institutional investors. 29.5% of GENinCode shares are owned by company insiders. Comparatively, 17.1% of Verici Dx shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Summary

GENinCode beats Verici Dx on 7 of the 10 factors compared between the two stocks.